Engagement With Digital Mental Health (DMH) Technologies in Pediatric Primary Care (TeACH)

November 6, 2025 updated by: Rush University Medical Center

Supporting Mental Health in Underserved Youth: Engagement With Digital Mental Health Technologies in Pediatric Primary Care

The goal of this study is to use and adapt existing digital mental health technologies to advance the engagement, assessment, detection, treatment, and delivery of services for pediatric mental health in families from underserved communities.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The goal of this study is to use and adapt existing digital mental health technologies to advance the engagement, assessment, detection, treatment, and delivery of services for pediatric mental health. Specifically, user-centered design methodologies and an implementation science framework will be used to guide the development and implementation of the Teen Assess, Check, and Heal (TeACH) System into a pediatric primary care clinic serving teens and families from underserved communities.

Study objectives include:

  1. Collaborating with underserved teens and their parents to identify strategies to target top barriers to engagement as well as top ethical concerns and requirements for cultural relevance, usability, and usefulness of the TeACH System (Phase 1)
  2. Refining the plan for implementing the TeACH System through observations, interviews, and co-design workshops with pediatric primary care pediatricians and staff (Phase 2), and
  3. Implementing the TeACH System into a primary care clinics and evaluating it in a randomized trial. (Phase 3)

The team will measure engagement outcomes and satisfaction with the TeACH System

Study Type

Interventional

Enrollment (Actual)

365

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60612
        • Rush University Medical Center
      • Chicago, Illinois, United States, 60601
        • University of Illinois at Chicago

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Are receiving care at specified Rush University Health System and University of Illinois at Chicago Pediatric Primary Care locations
  • Are between 13-17 years of age
  • Are able to speak and read in English
  • Symptoms of anxiety disorder

Exclusion Criteria:

  • Absence of the above inclusion criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TeACH System Resources
Patients who screen positive for anxiety will receive stakeholder-informed feedback and resources (i.e., psychoeducation and mental health recommendations).
Patients who screen positive for anxiety will receive psychoeducation and mental health recommendations (e.g., evidence-based apps) selected for use with the TeACH System through a collaborative, stakeholder-engaged approach completed in phases 1 and 2 of this project.
No Intervention: Evidence-based Resources
Patients who screen positive for anxiety will receive a link to a webpage providing psychoeducation about anxiety and possible treatment options.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Enrollment
Time Frame: Through study completion, an average of once per year.
We will track the number of teens who use the TeACH System during implementation phases and will compare this to the number of teens who were eligible but did not use the system.
Through study completion, an average of once per year.
Anxiety Understanding: Baseline
Time Frame: Administered following assent (in case of participant attrition through the interaction)
1 item (Likert Scale); We will ask participants to rate their understanding of anxiety on a Likert scale (1-5; 1 being "Not at All" and 5 being "Completely"). Specifically: "I understand what anxiety is."
Administered following assent (in case of participant attrition through the interaction)
Anxiety Understanding: Post Interaction
Time Frame: Administered immediately after receiving randomized feedback/resources
1 item (Likert Scale); We will ask participants to rate their understanding of anxiety on a Likert scale (1-5; 1 being "Not at All" and 5 being "Completely"). Specifically: "I understand what anxiety is."
Administered immediately after receiving randomized feedback/resources
Anxiety Understanding: Maintenance
Time Frame: Administered one week after interaction with TeACH System
1 item (Likert Scale); We will ask participants to rate their understanding of anxiety on a Likert scale (1-5; 1 being "Not at All" and 5 being "Completely"). Specifically: "I understand what anxiety is."
Administered one week after interaction with TeACH System
Confidence to Act: Baseline
Time Frame: Administered following assent (in case of participant attrition through the interaction)
1 item (Likert Scale); We will ask participants to rate how confident they feel to take action to help their anxiety symptoms on a Likert scale (1-5; 1 being "Not at All" to 5 being "Completely"). Specifically: "I feel confident I can do something if I feel anxiety."
Administered following assent (in case of participant attrition through the interaction)
Confidence to Act: Post Interaction
Time Frame: Administered immediately after receiving randomized feedback/resources
1 item (Likert Scale); We will ask participants to rate how confident they feel to take action to help their anxiety symptoms on a Likert scale (1-5; 1 being "Not at All" to 5 being "Completely"). Specifically: "I feel confident I can do something if I feel anxiety."
Administered immediately after receiving randomized feedback/resources
Confidence to Act: Maintenance
Time Frame: Administered one week after interaction with TeACH System
1 item (Likert Scale); We will ask participants to rate how confident they feel to take action to help their anxiety symptoms on a Likert scale (1-5; 1 being "Not at All" to 5 being "Completely"). Specifically: "I feel confident I can do something if I feel anxiety."
Administered one week after interaction with TeACH System
Likelihood of using DMH for Anxiety: Baseline
Time Frame: Administered following assent (in case of participant attrition through the interaction)
1 item (Likert Scale); We will ask participants to rate how likely they are to use digital mental health tools for their anxiety on a Likert scale (1-5; 1 being "Never" to 5 being "Absolutely"). Specifically: "If I feel anxiety, I would use a digital tool to help (app, website, reel/video)."
Administered following assent (in case of participant attrition through the interaction)
Likelihood of using DMH for Anxiety: Post Interaction
Time Frame: Administered immediately after receiving randomized feedback/resources
1 item (Likert Scale); We will ask participants to rate how likely they are to use digital mental health tools for their anxiety on a Likert scale (1-5; 1 being "Never" to 5 being "Absolutely"). Specifically: "If I feel anxiety, I would use a digital tool to help (app, website, reel/video)."
Administered immediately after receiving randomized feedback/resources
Likelihood of using DMH for Anxiety: Maintenance
Time Frame: Administered one week after interaction with TeACH System
1 item (Likert Scale); We will ask participants to rate how likely they are to use digital mental health tools for their anxiety on a Likert scale (1-5; 1 being "Never" to 5 being "Absolutely"). Specifically: "If I feel anxiety, I would use a digital tool to help (app, website, reel/video)."
Administered one week after interaction with TeACH System
DMH use for Anxiety: Baseline
Time Frame: Administered following assent (in case of participant attrition through the interaction)
1 item (Yes/No/Unsure); We will ask participants to report if they have used digital mental health tools for their anxiety symptoms. Specifically: "I have used a digital tool to help with anxiety (app, website, reel/video)."
Administered following assent (in case of participant attrition through the interaction)
DMH use for Anxiety: Post Interaction
Time Frame: Administered immediately after receiving randomized feedback/resources
1 item (Yes/No/Unsure); We will ask participants to report if they have used digital mental health tools for their anxiety symptoms. Specifically: "I have used a digital tool to help with anxiety (app, website, reel/video)."
Administered immediately after receiving randomized feedback/resources
DMH use for Anxiety: Maintenance, Change in DMH Use Following TeACH System Interaction
Time Frame: Administered one week after interaction with TeACH System
1 item (Yes/No/Unsure); We will ask participants to report if they have used digital mental health tools for their anxiety symptoms. Specifically: "I have used a digital tool to help with anxiety (app, website, reel/video)."
Administered one week after interaction with TeACH System

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kiddie-Computerized Adaptive Tests (K-CAT) Anxiety Module
Time Frame: Administered immediately after initiating use of the TeACH System; teen participants complete only once.
<1 minute to complete; Uses item response theory to pull from a large question item bank to accurately diagnose anxiety symptom severity.
Administered immediately after initiating use of the TeACH System; teen participants complete only once.
After-Scenario Questionnaire (ASQ): Post Interaction
Time Frame: Administered immediately after receiving randomized feedback/resources from TeACH System
3-item tool with seven response options (1-Strongly Disagree to 7-Strongly Agree) to assess satisfaction
Administered immediately after receiving randomized feedback/resources from TeACH System
After-Scenario Questionnaire (ASQ): Maintenance
Time Frame: Administered one week after interaction with TeACH System
3-item tool with seven response options (1-Strongly Disagree to 7-Strongly Agree) to assess satisfaction
Administered one week after interaction with TeACH System

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographics
Time Frame: Administered immediately after initiating use of the TeACH System; teen participants complete only once.
Name, date of birth, ethnicity, race, pronouns, gender, preferred language, reason for visiting primary care today, preferred channel of contact (i.e., text or email for follow-up)
Administered immediately after initiating use of the TeACH System; teen participants complete only once.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 16, 2024

Primary Completion (Actual)

November 6, 2025

Study Completion (Actual)

November 6, 2025

Study Registration Dates

First Submitted

July 14, 2022

First Submitted That Met QC Criteria

July 18, 2022

First Posted (Actual)

July 20, 2022

Study Record Updates

Last Update Posted (Estimated)

November 10, 2025

Last Update Submitted That Met QC Criteria

November 6, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • K08MH125069 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

Clinical Trials on TeACH System Resources

Subscribe